Product Code:162072
Published Date: Jul 21,2021
Pages: 83
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
According to this latest study, the 2021 growth of Basiliximab Injection will have significant change from previous year. By the most conservative estimates of global Basiliximab Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Basiliximab Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Basiliximab Injection market by product type, application, key manufacturers and key regions and countries. Segmentation by dosage type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7. 20 mL 10 mL Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8. Adult Use Pediatric Use This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3. Novartis AG Ryvis Pharma
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Basiliximab Injection Consumption 2016-2026
2.1.2 Basiliximab Injection Consumption CAGR by Region
2.2 Basiliximab Injection Segment by Dosage Type
2.2.1 20 mL
2.2.2 10 mL
2.3 Basiliximab Injection Sales by Dosage Type
2.3.1 Global Basiliximab Injection Sales Market Share by Dosage Type (2016-2021)
2.3.2 Global Basiliximab Injection Revenue and Market Share by Dosage Type (2016-2021)
2.3.3 Global Basiliximab Injection Sale Price by Dosage Type (2016-2021)
2.4 Basiliximab Injection Segment by Application
2.4.1 Adult Use
2.4.2 Pediatric Use
2.5 Basiliximab Injection Sales by Application
2.5.1 Global Basiliximab Injection Sale Market Share by Application (2016-2021)
2.5.2 Global Basiliximab Injection Revenue and Market Share by Application (2016-2021)
2.5.3 Global Basiliximab Injection Sale Price by Application (2016-2021)
3 Global Basiliximab Injection by Company
3.1 Global Basiliximab Injection Sales Market Share by Company
3.1.1 Global Basiliximab Injection Sales by Company (2019-2021)
3.1.2 Global Basiliximab Injection Sales Market Share by Company (2019-2021)
3.2 Global Basiliximab Injection Revenue Market Share by Company
3.2.1 Global Basiliximab Injection Revenue by Company (2019-2021)
3.2.2 Global Basiliximab Injection Revenue Market Share by Company (2019-2021)
3.3 Global Basiliximab Injection Sale Price by Company
3.4 Global Manufacturers Basiliximab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Basiliximab Injection Product Location Distribution
3.4.2 Players Basiliximab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Basiliximab Injection by Region
4.1 Global Basiliximab Injection by Region
4.1.1 Global Basiliximab Injection Sales by Region
4.1.2 Global Basiliximab Injection Revenue by Region
4.2 Americas Basiliximab Injection Sales Growth
4.3 APAC Basiliximab Injection Sales Growth
4.4 Europe Basiliximab Injection Sales Growth
4.5 Middle East & Africa Basiliximab Injection Sales Growth
5 Americas
5.1 Americas Basiliximab Injection Sales by Country
5.1.1 Americas Basiliximab Injection Sales by Country (2016-2021)
5.1.2 Americas Basiliximab Injection Revenue by Country (2016-2021)
5.2 Americas Basiliximab Injection Sales by Dosage Type
5.3 Americas Basiliximab Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Basiliximab Injection Sales by Region
6.1.1 APAC Basiliximab Injection Sales by Region (2016-2021)
6.1.2 APAC Basiliximab Injection Revenue by Region (2016-2021)
6.2 APAC Basiliximab Injection Sales by Dosage Type
6.3 APAC Basiliximab Injection Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Basiliximab Injection by Country
7.1.1 Europe Basiliximab Injection Sales by Country (2016-2021)
7.1.2 Europe Basiliximab Injection Revenue by Country (2016-2021)
7.2 Europe Basiliximab Injection Sales by Dosage Type
7.3 Europe Basiliximab Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Basiliximab Injection by Country
8.1.1 Middle East & Africa Basiliximab Injection Sales by Country (2016-2021)
8.1.2 Middle East & Africa Basiliximab Injection Revenue by Country (2016-2021)
8.2 Middle East & Africa Basiliximab Injection Sales by Dosage Type
8.3 Middle East & Africa Basiliximab Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Basiliximab Injection Distributors
10.3 Basiliximab Injection Customer
11 Global Basiliximab Injection Market Forecast
11.1 Global Basiliximab Injection Forecast by Region
11.1.1 Global Basiliximab Injection Forecast by Regions (2021-2026)
11.2.2 Global Basiliximab Injection Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Basiliximab Injection Forecast by Dosage Type
11.7 Global Basiliximab Injection Forecast by Application
12 Key Players Analysis
12.1 Novartis AG
12.1.1 Novartis AG Company Information
12.1.2 Novartis AG Basiliximab Injection Product Offered
12.1.3 Novartis AG Basiliximab Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Novartis AG Main Business Overview
12.1.5 Novartis AG Latest Developments
12.2 Ryvis Pharma
12.2.1 Ryvis Pharma Company Information
12.2.2 Ryvis Pharma Basiliximab Injection Product Offered
12.2.3 Ryvis Pharma Basiliximab Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Ryvis Pharma Main Business Overview
12.2.5 Ryvis Pharma Latest Developments
13 Research Findings and Conclusion
List of Tables Table 1. Basiliximab Injection Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of 20 mL Table 3. Major Players of 10 mL Table 4. Global Basiliximab Injection Sales by Dosage Type (2016-2021) & (KL) Table 5. Global Basiliximab Injection Sales Market Share by Dosage Type (2016-2021) Table 6. Global Basiliximab Injection Revenue by Dosage Type (2016-2021) & ($ million) Table 7. Global Basiliximab Injection Revenue Market Share by Dosage Type (2016-2021) Table 8. Global Basiliximab Injection Sale Price by Dosage Type (2016-2021) Table 9. Global Basiliximab Injection Sales by Application (2016-2021) & (KL) Table 10. Global Basiliximab Injection Sales Market Share by Application (2016-2021) Table 11. Global Basiliximab Injection Value by Application (2016-2021) Table 12. Global Basiliximab Injection Revenue Market Share by Application (2016-2021) Table 13. Global Basiliximab Injection Sale Price by Application (2016-2021) Table 14. Global Basiliximab Injection Sales by Company (2019-2021) & (KL) Table 15. Global Basiliximab Injection Sales Market Share by Company (2019-2021) Table 16. Global Basiliximab Injection Revenue by Company (2019-2021) ($ Millions) Table 17. Global Basiliximab Injection Revenue Market Share by Company (2019-2021) Table 18. Global Basiliximab Injection Sale Price by Company (2019-2021) Table 19. Key Manufacturers Basiliximab Injection Producing Area Distribution and Sales Area Table 20. Players Basiliximab Injection Products Offered Table 21. Basiliximab Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Basiliximab Injection Sales by Region (2016-2021) (KL) Table 25. Global Basiliximab Injection Sales Market Share by Region (2016-2021) Table 26. Global Basiliximab Injection Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Basiliximab Injection Revenue Market Share by Region (2016-2021) Table 28. Americas Basiliximab Injection Sales by Country (2016-2021) & (KL) Table 29. Americas Basiliximab Injection Sales Market Share by Country (2016-2021) Table 30. Americas Basiliximab Injection Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Basiliximab Injection Revenue Market Share by Country (2016-2021) Table 32. Americas Basiliximab Injection Sales by Type (2016-2021) & (KL) Table 33. Americas Basiliximab Injection Sales Market Share by Dosage Type (2016-2021) Table 34. Americas Basiliximab Injection Sales by Application (2016-2021) & (KL) Table 35. Americas Basiliximab Injection Sales Market Share by Application (2016-2021) Table 36. APAC Basiliximab Injection Sales by Region (2016-2021) & (KL) Table 37. APAC Basiliximab Injection Sales Market Share by Region (2016-2021) Table 38. APAC Basiliximab Injection Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Basiliximab Injection Revenue Market Share by Region (2016-2021) Table 40. APAC Basiliximab Injection Sales by Dosage Type (2016-2021) & (KL) Table 41. APAC Basiliximab Injection Sales Market Share by Dosage Type (2016-2021) Table 42. APAC Basiliximab Injection Sales by Application (2016-2021) & (KL) Table 43. APAC Basiliximab Injection Sales Market Share by Application (2016-2021) Table 44. Europe Basiliximab Injection Sales by Country (2016-2021) & (KL) Table 45. Europe Basiliximab Injection Sales Market Share by Country (2016-2021) Table 46. Europe Basiliximab Injection Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Basiliximab Injection Revenue Market Share by Country (2016-2021) Table 48. Europe Basiliximab Injection Sales by Type (2016-2021) & (KL) Table 49. Europe Basiliximab Injection Sales Market Share by Dosage Type (2016-2021) Table 50. Europe Basiliximab Injection Sales by Application (2016-2021) & (KL) Table 51. Europe Basiliximab Injection Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Basiliximab Injection Sales by Country (2016-2021) & (KL) Table 53. Middle East & Africa Basiliximab Injection Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Basiliximab Injection Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Basiliximab Injection Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Basiliximab Injection Sales by Dosage Type (2016-2021) & (KL) Table 57. Middle East & Africa Basiliximab Injection Sales Market Share by Dosage Type (2016-2021) Table 58. Middle East & Africa Basiliximab Injection Sales by Application (2016-2021) & (KL) Table 59. Middle East & Africa Basiliximab Injection Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Basiliximab Injection Table 61. Key Application and Potential Industries of Basiliximab Injection Table 62. Key Challenges of Basiliximab Injection Table 63. Key Trends of Basiliximab Injection Table 64. Basiliximab Injection Distributors List Table 65. Basiliximab Injection Customer List Table 66. Global Basiliximab Injection Sales Forecast by Region (2021-2026) & (KL) Table 67. Global Basiliximab Injection Consumption Market Forecast by Region Table 68. Global Basiliximab Injection Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Basiliximab Injection Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Basiliximab Injection Sales Forecast by Country (2021-2026) & (KL) Table 71. Americas Basiliximab Injection Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Basiliximab Injection Sales Forecast by Region (2021-2026) & (KL) Table 73. APAC Basiliximab Injection Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Basiliximab Injection Sales Forecast by Country (2021-2026) & (KL) Table 75. Europe Basiliximab Injection Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Basiliximab Injection Sales Forecast by Country (2021-2026) & (KL) Table 77. Middle East & Africa Basiliximab Injection Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Basiliximab Injection Sales Forecast by Dosage Type (2021-2026) & (KL) Table 79. Global Basiliximab Injection Sales Market Share Forecast by Dosage Type (2021-2026) Table 80. Global Basiliximab Injection Revenue Forecast by Dosage Type (2021-2026) & ($ Millions) Table 81. Global Basiliximab Injection Revenue Market Share Forecast by Dosage Type (2021-2026) Table 82. Global Basiliximab Injection Sales Forecast by Application (2021-2026) & (KL) Table 83. Global Basiliximab Injection Sales Market Share Forecast by Application (2021-2026) Table 84. Global Basiliximab Injection Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Basiliximab Injection Revenue Market Share Forecast by Application (2021-2026) Table 86. Novartis AG Basic Information, Basiliximab Injection Manufacturing Base, Sales Area and Its Competitors Table 87. Novartis AG Basiliximab Injection Product Offered Table 88. Novartis AG Basiliximab Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2021E) Table 89. Novartis AG Main Business Table 90. Novartis AG Latest Developments Table 91. Ryvis Pharma Basic Information, Basiliximab Injection Manufacturing Base, Sales Area and Its Competitors Table 92. Ryvis Pharma Basiliximab Injection Product Offered Table 93. Ryvis Pharma Basiliximab Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2021E) Table 94. Ryvis Pharma Main Business Table 95. Ryvis Pharma Latest Developments List of Figures Figure 1. Picture of Basiliximab Injection Figure 2. Basiliximab Injection Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Basiliximab Injection Sales Growth Rate 2016-2026 (KL) Figure 7. Global Basiliximab Injection Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Basiliximab Injection Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of 20 mL Figure 10. Product Picture of 10 mL Figure 11. Global Basiliximab Injection Sales Market Share by Dosage Type in 2020 Figure 12. Global Basiliximab Injection Revenue Market Share by Dosage Type (2016-2021) Figure 13. Basiliximab Injection Consumed in Adult Use Figure 14. Global Basiliximab Injection Market: Adult Use (2016-2021) & (KL) Figure 15. Basiliximab Injection Consumed in Pediatric Use Figure 16. Global Basiliximab Injection Market: Pediatric Use (2016-2021) & (KL) Figure 17. Global Basiliximab Injection Sales Market Share by Application (2016-2021) Figure 18. Global Basiliximab Injection Revenue Market Share by Application in 2020 Figure 19. Basiliximab Injection Revenue Market by Company in 2020 ($ Million) Figure 20. Global Basiliximab Injection Revenue Market Share by Company in 2020 Figure 21. Global Basiliximab Injection Sales Market Share by Regions (2016-2021) Figure 22. Global Basiliximab Injection Revenue Market Share by Region in 2020 Figure 23. Americas Basiliximab Injection Sales 2016-2021 (KL) Figure 24. Americas Basiliximab Injection Revenue 2016-2021 ($ Millions) Figure 25. APAC Basiliximab Injection Sales 2016-2021 (KL) Figure 26. APAC Basiliximab Injection Revenue 2016-2021 ($ Millions) Figure 27. Europe Basiliximab Injection Sales 2016-2021 (KL) Figure 28. Europe Basiliximab Injection Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Basiliximab Injection Sales 2016-2021 (KL) Figure 30. Middle East & Africa Basiliximab Injection Revenue 2016-2021 ($ Millions) Figure 31. Americas Basiliximab Injection Sales Market Share by Country in 2020 Figure 32. Americas Basiliximab Injection Revenue Market Share by Country in 2020 Figure 33. Americas Basiliximab Injection Sales Market Share by Dosage Type in 2020 Figure 34. Americas Basiliximab Injection Sales Market Share by Application in 2020 Figure 35. United States Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Basiliximab Injection Sales Market Share by Region in 2020 Figure 40. APAC Basiliximab Injection Revenue Market Share by Regions in 2020 Figure 41. APAC Basiliximab Injection Sales Market Share by Dosage Type in 2020 Figure 42. APAC Basiliximab Injection Sales Market Share by Application in 2020 Figure 43. China Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 47. India Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Basiliximab Injection Sales Market Share by Country in 2020 Figure 50. Europe Basiliximab Injection Revenue Market Share by Country in 2020 Figure 51. Europe Basiliximab Injection Sales Market Share by Dosage Type in 2020 Figure 52. Europe Basiliximab Injection Sales Market Share by Application in 2020 Figure 53. Germany Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 54. France Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Basiliximab Injection Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Basiliximab Injection Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Basiliximab Injection Sales Market Share by Dosage Type in 2020 Figure 61. Middle East & Africa Basiliximab Injection Sales Market Share by Application in 2020 Figure 62. Egypt Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Basiliximab Injection Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles
Novartis AG Ryvis Pharma
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape
RELATED REPORTS
Jan
2024
Global Basiliximab Injection Market Growth 2024-2030
Pages: 78|Category: PHARMA & HEALTHCARE
According to our LPI (LP Information) latest study, the global Basiliximab Injection market size was valued at US$ million in 2023. With growing demand in downstream market, the Basiliximab Injection is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
$3660.00